Background: Hypertension management in older patients represents a challenge, particularly when hospitalized.Objective: The objective of this study is to investigate the determinants and related outcomes of antihypertensive drug prescription in a cohort of older hospitalized patients.Methods: A total of 5671 patients from REPOSI (a prospective multicentre observational register of older Italian in-patients from internal medicine or geriatric wards) were considered; 4377 (77.2%) were hypertensive. Minimum treatment (MT) for hypertension was defined according to the 2018 ESC guidelines [an angiotensin-converting-enzyme-inhibitor (ACE-I) or an angiotensin-receptorblocker (ARB) with a calcium- channel-blocker (CCB) and/or a thiazide diuretic; if > 80 years old, an ACE I or ARB or CCB or thiazide diuretic]. Determinants of MT discontinuation at discharge were assessed. Study outcomes were any cause rehospitalization/all cause death, all cause death, cardiovascular (CV) hospitalization/death, CV death, non CV death, evaluated according to the presence of MT at discharge.Results: Hypertensive patients were older than normotensives, with a more impaired functional status, higher burden of comorbidity and polypharmacy. A total of 2233 patients were on MT at admission, 1766 were on MT at discharge. Discontinuation of MT was associated with the presence of comorbidities (lower odds for diabetes, higher odds for chronic kidney disease and dementia). An adjusted multivariable logistic regression analysis showed that MT for hypertension at discharge was associated with lower risk of all cause death, all cause death/hospitalization, CV death, CV death/hospitalization and non-CV death. Conclusions: Guidelines-suggested MT for hypertension at discharge is associated with a lower risk of adverse clinical outcomes. Nevertheless, changes in anti hypertensive treatment still occur in a significant proportion of older hospitalized patients.

Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients / Cicco, Sebastiano; D Abbondanza, Marco; Proietti, Marco; Zaccone, Vincenzo; Pes, Chiara; Caradio, Federica; Mattioli, Massimo; Piano, Salvatore; Marra, Alberto Maria; Nobili, Alessandro; Mannucci, Pier Mannuccio; Pietrangelo, Antonello; Sesti, Giorgio; Buzzetti, Elena; Salzano, Andrea; Cimellaro, Antonio; Giovani Internisti Società Italiana di Medicina Interna (GIS-SIMI) and of the REPOSI, Investigators; Colangelo, Luciano. - In: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - ISSN 0014-2972. - 53:4(2023). [10.1111/eci.13931]

Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients

Proietti, Marco;Mattioli, Massimo;Marra, Alberto Maria;Sesti, Giorgio
Supervision
;
Colangelo, Luciano
Membro del Collaboration Group
2023

Abstract

Background: Hypertension management in older patients represents a challenge, particularly when hospitalized.Objective: The objective of this study is to investigate the determinants and related outcomes of antihypertensive drug prescription in a cohort of older hospitalized patients.Methods: A total of 5671 patients from REPOSI (a prospective multicentre observational register of older Italian in-patients from internal medicine or geriatric wards) were considered; 4377 (77.2%) were hypertensive. Minimum treatment (MT) for hypertension was defined according to the 2018 ESC guidelines [an angiotensin-converting-enzyme-inhibitor (ACE-I) or an angiotensin-receptorblocker (ARB) with a calcium- channel-blocker (CCB) and/or a thiazide diuretic; if > 80 years old, an ACE I or ARB or CCB or thiazide diuretic]. Determinants of MT discontinuation at discharge were assessed. Study outcomes were any cause rehospitalization/all cause death, all cause death, cardiovascular (CV) hospitalization/death, CV death, non CV death, evaluated according to the presence of MT at discharge.Results: Hypertensive patients were older than normotensives, with a more impaired functional status, higher burden of comorbidity and polypharmacy. A total of 2233 patients were on MT at admission, 1766 were on MT at discharge. Discontinuation of MT was associated with the presence of comorbidities (lower odds for diabetes, higher odds for chronic kidney disease and dementia). An adjusted multivariable logistic regression analysis showed that MT for hypertension at discharge was associated with lower risk of all cause death, all cause death/hospitalization, CV death, CV death/hospitalization and non-CV death. Conclusions: Guidelines-suggested MT for hypertension at discharge is associated with a lower risk of adverse clinical outcomes. Nevertheless, changes in anti hypertensive treatment still occur in a significant proportion of older hospitalized patients.
2023
antihypertensive drugs; cardiovascular events; hypertension; older patients; survival
01 Pubblicazione su rivista::01a Articolo in rivista
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients / Cicco, Sebastiano; D Abbondanza, Marco; Proietti, Marco; Zaccone, Vincenzo; Pes, Chiara; Caradio, Federica; Mattioli, Massimo; Piano, Salvatore; Marra, Alberto Maria; Nobili, Alessandro; Mannucci, Pier Mannuccio; Pietrangelo, Antonello; Sesti, Giorgio; Buzzetti, Elena; Salzano, Andrea; Cimellaro, Antonio; Giovani Internisti Società Italiana di Medicina Interna (GIS-SIMI) and of the REPOSI, Investigators; Colangelo, Luciano. - In: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - ISSN 0014-2972. - 53:4(2023). [10.1111/eci.13931]
File allegati a questo prodotto
File Dimensione Formato  
Cicco_Antihypertensive_2023.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 675.28 kB
Formato Adobe PDF
675.28 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1674314
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact